Advertisement

ADVERTISEMENT

Heather Flint

Youth_Depression_Suicide
Videos
Elevate Exclusive Preview: Hiding in Plain Sight
05/16/2022
This year, Psych Congress Elevate is working to shine a spotlight on the mental health of America’s youth with a preview of the documentary, “Hiding in Plain Sight: Youth Mental Illness.”
This year, Psych Congress Elevate is working to shine a spotlight on the mental health of America’s youth with a preview of the documentary, “Hiding in Plain Sight: Youth Mental Illness.”
This year, Psych Congress...
05/16/2022
Psychiatry & Behavioral Health
News
Six-Month LAI for Treatment of Schizophrenia in Adults Approved by FDA
09/28/2021
The US FDA has approved Janssen Pharmaceutical’s INVEGA HAFYERA (6-month paliperidone palmitate), a long-acting, atypical antipsychotic for adults with schizophrenia.
The US FDA has approved Janssen Pharmaceutical’s INVEGA HAFYERA (6-month paliperidone palmitate), a long-acting, atypical antipsychotic for adults with schizophrenia.
The US FDA has approved Janssen...
09/28/2021
Psych Congress Network
News
NDA Submission for Major Depressive Disorder and Postpartum Depression Treatments
10/20/2021
New drug application to be submitted to the FDA for a novel therapeutic for the treatment of both major depressive disorder and postpartum depression.
New drug application to be submitted to the FDA for a novel therapeutic for the treatment of both major depressive disorder and postpartum depression.
New drug application to be...
10/20/2021
Psych Congress Network
Bipolar Disorder_APA
Conference Coverage
APA Bipolar Disorder Preview: What to Expect
05/17/2022
A preview for the APA annual meeting: what to expect for bipolar disorder session.
A preview for the APA annual meeting: what to expect for bipolar disorder session.
A preview for the APA annual...
05/17/2022
Psych Congress Network
News
Leading Their Patients on the Psychedelic Therapy Journey: Considerations for Clinicians
09/18/2021
There are several “important considerations for the clinician” in preparing to help lead their client on the journey of psychedelic therapies, said Julie Megler, PHH-NP, at today’s SANA Symposium.
There are several “important considerations for the clinician” in preparing to help lead their client on the journey of psychedelic therapies, said Julie Megler, PHH-NP, at today’s SANA Symposium.
There are several “important...
09/18/2021
Psych Congress Network
News
Lynn-Marie Morski and Rosalind Watts, Most Influential Women in Psychedelics
02/22/2022
Sana Symposium Steering Committee Members, Lynn-Marie Morski, MD, JD, and Rosalind Watts, MD, named 2 of the 16 most influential women in the psychedelic space.
Sana Symposium Steering Committee Members, Lynn-Marie Morski, MD, JD, and Rosalind Watts, MD, named 2 of the 16 most influential women in the psychedelic space.
Sana Symposium Steering...
02/22/2022
Psych Congress Network
News
FDA Approves Donepezil Transdermal Patch for Alzheimer Disease
03/21/2022
The US Food and Drug Administration has approved Adlarity® (donepezil transdermal system) for release in the fall of 2022. Adlarity is indicated in the treatment of adults with Alzeheimer-type mild to severe dementia symptoms. Adlarity is...
The US Food and Drug Administration has approved Adlarity® (donepezil transdermal system) for release in the fall of 2022. Adlarity is indicated in the treatment of adults with Alzeheimer-type mild to severe dementia symptoms. Adlarity is...
The US Food and Drug...
03/21/2022
Psych Congress Network
News
The Impact of Pandemic-related Lockdown on Children With ADHD
09/17/2021
According to a recent study, the effects of the COVID-19 pandemic-related lockdown significantly impacted most of the global population, specifically children and adolescents with ADHD.
According to a recent study, the effects of the COVID-19 pandemic-related lockdown significantly impacted most of the global population, specifically children and adolescents with ADHD.
According to a recent study, the...
09/17/2021
Psych Congress Network
News
Valbenazine Use for Tardive Dyskinesia in Older Adults Proves Efficacious
12/08/2021
Valbenazine use for tardive dyskinesia (TD) in adults aged 65 and older has been deemed efficacious with comparable outcomes to younger adults, according to a post hoc analysis.
Valbenazine use for tardive dyskinesia (TD) in adults aged 65 and older has been deemed efficacious with comparable outcomes to younger adults, according to a post hoc analysis.
Valbenazine use for tardive...
12/08/2021
Psych Congress Network
Suicide_Screener_Tools
Perspectives
Suicide Awareness: Rates and Statistics
09/07/2021
September is National Suicide Awareness Month, and September 5 to September 11 is National Suicide Prevention Week. Suicide crosses all age groups, races, ethnicities, and class lines, proving that mental health struggles can impact anyone.
September is National Suicide Awareness Month, and September 5 to September 11 is National Suicide Prevention Week. Suicide crosses all age groups, races, ethnicities, and class lines, proving that mental health struggles can impact anyone.
September is National Suicide...
09/07/2021
Psych Congress Network

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

November 23 ⁠–⁠ November 24
December 4 ⁠–⁠ December 5
Great Debates & Updates in Diabetic Foot
December 6 ⁠–⁠ December 7
AIBD logo
December 9 ⁠–⁠ December 11
December 9 ⁠–⁠ December 11
Psych Congress Primary Care Online Series
December 12 ⁠–⁠ December 13
December 14 ⁠–⁠ December 15
February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use